Items where Author is "Roth, A."
Number of items: 9. 2016Berger, B. and Donzelli, M. and Maseneni, S. and Boess, F. and Roth, A. and Krahenbuhl, S. and Haschke, M.. (2016) Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail. Front Pharmacol, 7. p. 443. 2015Köberle, D. and Betticher, D. C. and von Moos, R. and Dietrich, D. and Brauchli, B. and Baertschi, D. and Matter, K. and Winterhalder, R. and Borner, M. and Anchisi, S. and Moosmann, P. and Kollar, A. and Saletti, P. and Roth, A. and Frueh, M. and Kueng, M. and Popescu, R. A. and Schacher, S. and Hess, V. and Herrmann, R.. (2015) Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26 (4). pp. 709-714. 2011Durrer, H. and Luka, H. and Lenzin, H. and Glasstetter, M. and Luka, A. and Roth, A.. (2011) Epigäische Arthropodenfauna (und Regenwürmer) der Petite Camargue Alsacienne : Untersuchungsjahr 2008. St. Louis. 2009Ribi, K. and Koeberle, D. and Schuller, J. C. and Honegger, H. and Roth, A. and Hess, V. and Moosmann, P. and von Moos, R. and Borner, M. and Lombriser, N. and Pestalozzi, B. and Ruhstaller, T.. (2009) Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Vol. 17. pp. 1109-1116. Ruhstaller, T. and Widmer, L. and Schuller, J. C. and Roth, A. and Hess, V. and Mingrone, W. and von Moos, R. and Borner, M. and Pestalozzi, B. C. and Balmermajno, S. and Köberle, D. and Terraciano, L. and Schnider, A. and Bodis, S. and Popescu, R.. (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. pp. 1522-1528. 2008Borner, M. and Koeberle, D. and Von Moos, R. and Saletti, P. and Rauch, D. and Hess, V. and Trojan, A. and Helbling, D. and Pestalozzi, B. and Caspar, C. and Ruhstaller, T. and Roth, A. and Kappeler, A. and Dietrich, D. and Lanz, D. and Mingrone, W. and Swiss, Group for Clinical Cancer Research and Bern, and Switzerland, . (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer : a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, Vol. 19, H. 7. pp. 1288-1292. 2007Scarsi, M. and Podvinec, M. and Roth, A. and Hug, H. and Kersten, S. and Albrecht, H. and Schwede, T. and Meyer, U. A. and Rucker, C.. (2007) Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity : a combined virtual screening and biological assay approach. Molecular pharmacology, Vol. 71, H. 2. pp. 398-406. 2005Gnerre, C. and Schuster, G. U. and Roth, A. and Handschin, C. and Johansson, L. and Looser, R. and Parini, P. and Podvinec, M. and Robertsson, K. and Gustafsson, J. -A. and Meyer, U. A.. (2005) LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver. Journal of Lipid Research, 46 (8). pp. 1633-1642. 2004Handschin, C. and Blattler, S. and Roth, A. and Looser, R. and Oscarson, M. and Kaufmann, M. R. and Podvinec, M. and Gnerre, C. and Meyer, U. A.. (2004) The evolution of drug-activated nuclear receptors : one ancestral gene diverged into two xenosensor genes in mammals. Nuclear Receptor, Vol. 2, H. 1. p. 7. |
